| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/20/2013 | US8512748 Controlled release system and method for manufacturing the same |
| 08/20/2013 | US8512747 Pharmaceutical composition for the treatment of acute disorders |
| 08/20/2013 | US8512746 Extended release pharmaceutical compositions of levetiracetam |
| 08/20/2013 | US8512745 Ulipristal acetate tablets |
| 08/20/2013 | US8512744 Sustained release micropellets and process for producing the same |
| 08/20/2013 | US8512743 Devices and methods for the delivery of molecular sieve materials for the formation of blood clots |
| 08/20/2013 | US8512742 Transdermal preparation |
| 08/20/2013 | US8512740 Fibrin foam and process for making |
| 08/20/2013 | US8512738 Biodegradable intravitreal tyrosine kinase implants |
| 08/20/2013 | US8512734 Biocompatible coating of medical devices |
| 08/20/2013 | US8512729 Fragmented polymeric compositions and methods for their use |
| 08/20/2013 | US8512727 Nanoparticulate meloxicam formulations |
| 08/20/2013 | US8512723 Decontamination of vegetables, meats or fruits by disinfection of such with antimicrobial solution containing lipid and enhancer such as bacteriocins, sugars and enzymes |
| 08/20/2013 | US8512718 Pharmaceutical composition for topical application |
| 08/20/2013 | US8512717 A therapeutic component such as quinoxaline derivative, an ophthalmically acceptable carrier component, a retention component; an increased penetration of the therapeutic component through the cornea and into the eye |
| 08/20/2013 | US8512681 Chewing gum possessing tooth cleaning effect and a teeth cleaning method |
| 08/20/2013 | US8512680 Injectables in foam, new pharmaceutical applications |
| 08/20/2013 | US8512314 Patient controlled analgesia for pediatric patients |
| 08/20/2013 | US8511318 Electronic cigarette |
| 08/20/2013 | CA2651451C Extended release oral multimicroparticle dosage form |
| 08/20/2013 | CA2634232C Method of producing solid preparation disintegrating in the oral cavity |
| 08/20/2013 | CA2587924C Oral compositions for absorption of phosphorus compounds |
| 08/20/2013 | CA2587169C Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 08/20/2013 | CA2545219C Efficient introduction of an aerosol into a ventilator circuit |
| 08/20/2013 | CA2520660C Solid oral dosage form containing seamless microcapsules |
| 08/20/2013 | CA2504329C Geodate delivery vehicles |
| 08/20/2013 | CA2488558C Prevention and reduction of blood loss |
| 08/20/2013 | CA2398723C Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase |
| 08/15/2013 | WO2013119988A1 Pharmaceutical compositions to reduce complications of ocular steroid |
| 08/15/2013 | WO2013119974A1 Aqueous pharmaceutical composition with enhanced stability |
| 08/15/2013 | WO2013119917A1 Materials and methods for treating diarrhea |
| 08/15/2013 | WO2013119856A1 Improved adjuvant formulations comprising tlr4 agonists and methods of using the same |
| 08/15/2013 | WO2013119794A1 Modified release formulations of viloxazine |
| 08/15/2013 | WO2013119760A1 Multi-layer nicotine-containing pharmaceutical composition |
| 08/15/2013 | WO2013119633A1 Silicone emulsions for delivery of healthcare actives |
| 08/15/2013 | WO2013119607A2 Modified release formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione |
| 08/15/2013 | WO2013119582A1 Drug release from a polymer-controlled local antibiotic delivery system using a degradable bone graft |
| 08/15/2013 | WO2013119551A1 Multi-layer biomaterial for tissue regeneration and wound healing |
| 08/15/2013 | WO2013119508A1 Adhesive patch with antimicrobial composition |
| 08/15/2013 | WO2013119466A1 Rapidly disintegrating coated tablets |
| 08/15/2013 | WO2013119384A1 Acidic aqueous product comprising oil-containing microcapsules and method for the manufacture thereof |
| 08/15/2013 | WO2013119231A1 Abuse resistant opioid drug - ion exchange resin complexes having hybrid coatings |
| 08/15/2013 | WO2013119183A1 Methods of manufacturing core-shell microparticles, and microparticles formed thereof |
| 08/15/2013 | WO2013119059A1 Injectable composition containing phosphatidylcholine devoid of sodium deoxycholate and preparing method thereof |
| 08/15/2013 | WO2013118092A1 Pharmaceutical dosage form |
| 08/15/2013 | WO2013117969A1 Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis |
| 08/15/2013 | WO2013117963A1 Stable oral tablet dosage form of an antidiabetic compound |
| 08/15/2013 | WO2013117012A1 Kit and method for visualizing whitening benefit of cosmetic composition |
| 08/15/2013 | WO2013117008A1 Composition comprising hawthorn and phytosterols |
| 08/15/2013 | WO2013095042A3 Granule containing imatinib mesylate, immediate release oral tablet composition containing same, and preparation method thereof |
| 08/15/2013 | WO2013093524A3 Method for preparing amorphous precipitated protein particles |
| 08/15/2013 | WO2013072763A3 Non-sensitizing transdermal clonidine patch |
| 08/15/2013 | WO2013072686A3 Self-assembling peptides and hydrogels comprising them |
| 08/15/2013 | WO2013067271A3 Stable dermatological aerosol foams utilizing reactive propellants |
| 08/15/2013 | US20130211490 Everolimus Eluting Bioabsorbable Renal Artery Stent For Renal Cancer And Inflammatory Disorders |
| 08/15/2013 | US20130211368 Microfabricated nanopore device for sustained release of therapeutic agent |
| 08/15/2013 | US20130211352 Percutaneously absorbed preparation |
| 08/15/2013 | US20130211351 Pharmaceutical patch for transdermal administration of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine |
| 08/15/2013 | US20130211347 Stiffener for use with a drug patch |
| 08/15/2013 | US20130210929 Topical germicidal compositions |
| 08/15/2013 | US20130210925 Subunguicide, and method for treating onychomycosis |
| 08/15/2013 | US20130210922 Stable ready to use injectable paracetamol formulation |
| 08/15/2013 | US20130210916 Thermally stable oil-in-water emulsions containing an oil that contains polyunsaturated fatty acids |
| 08/15/2013 | US20130210898 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same |
| 08/15/2013 | US20130210869 Method of increasing the extent of absorption of tizanidine |
| 08/15/2013 | US20130210868 Stable topical compositions for 1,2,4-thiadiazole derivatives |
| 08/15/2013 | US20130210862 Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
| 08/15/2013 | US20130210854 Compositions Comprising Enzyme-Cleavable Prodrugs of Active Agents and Inhibitors Thereof |
| 08/15/2013 | US20130210853 Injectable Flowable Composition Comprising Buprenorphine |
| 08/15/2013 | US20130210841 Mucoadhesive buccal tablets for the treatment of orofacial herpes |
| 08/15/2013 | US20130210791 Testosterone gel and method of use |
| 08/15/2013 | US20130210790 Testosterone gel and method of use |
| 08/15/2013 | US20130210789 Testosterone gel and method of use |
| 08/15/2013 | US20130210778 Formulation for the prevention of cardiovascular disease |
| 08/15/2013 | US20130210729 Non-aqueous oily injectable formulation exhibiting preservative efficacy |
| 08/15/2013 | US20130210725 Conditioned cell culture medium compositions and methods of use |
| 08/15/2013 | US20130210715 Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition |
| 08/15/2013 | US20130210136 Methods For Treating Cardio Pulmonary Diseases With NO Group Compounds |
| 08/15/2013 | US20130210076 Conditioned cell culture medium compositions and methods of use |
| 08/15/2013 | US20130209570 Drug delivery systems and use thereof |
| 08/15/2013 | US20130209569 Novel formulation of diclofenac |
| 08/15/2013 | US20130209568 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides |
| 08/15/2013 | US20130209567 Modified Release Dosage Forms of Skeletal Muscle Relaxants |
| 08/15/2013 | US20130209566 Nanoparticle composition and methods to make and use the same |
| 08/15/2013 | US20130209562 Methods and devices for providing prolonged drug therapy |
| 08/15/2013 | US20130209561 Abuse-resistant opioid dosage form |
| 08/15/2013 | US20130209560 Abuse-resistant formulations |
| 08/15/2013 | US20130209559 Method for treating intestinal diseases presenting at least one inflammatory component |
| 08/15/2013 | US20130209555 Formulations and Dosage Forms of Oxidized Phospholipids |
| 08/15/2013 | US20130209554 Novel gelatin capsule compositions and methods of making |
| 08/15/2013 | US20130209553 Extended release pharmaceutical compositions of pramipexole |
| 08/15/2013 | US20130209552 Aripiprazole compositions and methods for its transdermal delivery |
| 08/15/2013 | US20130209548 Sustained release formulation of a non-steroidal anti-inflammatory drug |
| 08/15/2013 | US20130209547 Sustained release formulation of a non-steroidal anti-inflammatory drug |
| 08/15/2013 | US20130209544 Microvesicles carrying small interfering rnas, preparation methods and uses thereof |
| 08/15/2013 | US20130209542 Pharmaceutical carrier and pharmaceutical composition for inhibiting angiogenesis |
| 08/15/2013 | US20130209540 Multi-layer nicotine-containing pharmaceutical composition |
| 08/15/2013 | US20130209539 Core sheath drug delivery devices |
| 08/15/2013 | US20130209536 Antimicrobial elastomeric articles |
| 08/15/2013 | US20130209530 "nanoparticles for the encapsulation of compounds, preparation thereof and use of same" |